MEDGX | PAIKX | MEDGX / PAIKX | |
Total Expense Ratio | 0.81 | 1.15 | 70% |
Annual Report Gross Expense Ratio | 0.82 | 2.55 | 32% |
Fund Existence | 17 years | 10 years | - |
Gain YTD | 8.433 | 9.665 | 87% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.45B | 5.06B | 147% |
Annual Yield % from dividends | 5.67 | 5.68 | 100% |
Returns for 1 year | 8.23 | 9.40 | 87% |
Returns for 3 years | 30.90 | 34.19 | 90% |
Returns for 5 years | 11.77 | 10.66 | 110% |
Returns for 10 years | 49.21 | 39.24 | 125% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LZSIX | 12.54 | N/A | N/A |
Lazard International Equity Select Instl | |||
JIISX | 84.94 | N/A | N/A |
JPMorgan US Sustainable Leaders I | |||
OPGIX | 50.80 | N/A | N/A |
Invesco Global Opportunities A | |||
TQSIX | 24.82 | N/A | N/A |
T. Rowe Price Integrated US SMCC Eq I | |||
MLRTX | 10.56 | N/A | N/A |
NYLI Winslow Large Cap Growth Class R2 |